Global Scans · Genetics · Weekly Summary

• [New] Neighborhood vulnerability may contribute to differences in genetic testing uptake, which is crucial to increasing early detection of cancer susceptibility and reducing US cancer incidence. PubMed Central (PMC)
• [New] Findings from the Irish Lifeways cross-generational cohort study and the Generation R Study suggest that paternal BMI and dietary quality (assessed using the Dietary Approaches to Stop Hypertension and dietary inflammatory index) influence post-natal offspring adiposity risk. PubMed Central (PMC)
• [New] Recent findings from the French ELFE and Dutch Generation R cohort further demonstrated that the previously identified parental lifestyle patterns during pregnancy can partially explain the association of parental socio-economic position with childhood overweight risk. PubMed Central (PMC)
• [New] Kelleher argues that TSMC will continue to benefit as generative AI becomes more mainstream in the coming years. NAI 500
• [New] The task force specifically targets California laws AB 2602 and AB 1836, which shield performers from unauthorized AI generated replicas of their voices and likenesses. AI FILMS Studio
• [New] SAG-AFTRA strikes in 2023 highlighted performers' fears of job loss from unauthorized voice clones in films and ads, prompting AB 2602 and AB 1836 to modernize right-of-publicity statutes for the AI era. Real AI Voice & Web Solutions That Work | Avius AI
• [New] In 2026, healthcare AI will shift from generative content to agentic AI; intelligent agents capable of executing complex clinical tasks and seamlessly integrating into healthcare workflows will become mainstream, evolving from assistive tools to decision-making partners for physicians. Healthcare IT News
• [New] 2026 Prediction: Specialization over generalization: legal AI will be defined less by generic chat interfaces and more by specialized tools embedded into legal workflows, designed to handle specific legal tasks with greater consistency and efficiency. National Law Review
• [New] By 2028, most enterprise generative AI applications will be based on domain-specific models - not generic LLMs. TI INSIDE Online
• [New] By 2028, more than 60% of generative AI models used by enterprises will be domain-specific. DigitalMara
• [New] Generative AI will continue to transform the way work is done across industries in 2026 and beyond. CloudThat Resources
• [New] Generative AI could affect up to 300 million jobs globally - around 9.1% of workers - yet their economists project only about a 0.5 percentage point increase in unemployment, with many effects expected to be temporary as new roles appear. Nucamp Bootcamp
• [New] Predicts 90% of world's knowledge will be generated by AI within 2-3 years. C5FA: Co-create Fair, Free, Flourishing Futures For All
• [New] 90% of the world's knowledge will be generated by AI within 2-3 years, representing a radical shift in content creation dynamics. C5FA: Co-create Fair, Free, Flourishing Futures For All
• [New] As AI workloads grow through 2026, facilities built in 2025 will be expected to scale capacity, maintain efficiency and support next generation compute requirements. English
• [New] A combination of economic, geopolitical and technological tensions is reshaping the global landscape, generating new economic uncertainty and social vulnerabilities. The Tribune
• [New] Gene editing is expected to gain fresh momentum in 2026, particularly for children with rare genetic diseases. tovima.com
• [New] A Gene, Cell & RNA Therapy Report indicated that oncology and rare diseases remain the top areas of development, which is a continuing trend, whilst advanced therapies are projected to grow at a compound annual growth rate of 18% through 2033. NES Fircroft
• [New] While Novo's secondary patents on formulations and methods extend protection into 2033 in some regions, core patent expirations will inevitably accelerate generic competition. / China Pharmaphorum
• [New] 2028 will be the first year when a negotiated drug becomes ineligible for negotiated prices for the first time because generic competition, as Januvia and Janumet are expected to have generic competition launch in mid-2026. PubMed Central (PMC)
• [New] Two years prior to the implementation of negotiated prices, CMS will begin negotiation on the top eligible drugs based on age and generic / biosimilar availability by gross spend, although negotiation for 2026 will begin in 2023 under a timeline provided by CMS. PubMed Central (PMC)
• [New] In 2026, most primary care providers at Somerville, Mass.-based Mass General Brigham will no longer be in network with MA plans from UnitedHealthcare or BCBS Massachusetts. Becker's Hospital Review | Healthcare News & A

Last updated: 11 January 2026